|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn706130457 |
003 |
OCoLC |
005 |
20231117044554.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110308s2011 ne a ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d OL$
|d UHL
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9780123858566
|q (electronic bk.)
|
020 |
|
|
|a 0123858569
|q (electronic bk.)
|
020 |
|
|
|a 9780123858559
|q (electronic bk.)
|
020 |
|
|
|a 0123858550
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)706130457
|
050 |
|
4 |
|a RB40
|b .A38 vol. 53eb
|
072 |
|
7 |
|a SCI
|x 013020
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07/56
|2 22
|
245 |
0 |
0 |
|a Advances in clinical chemistry.
|n Vol. 53 /
|c edited by Gregory S. Makowski.
|
260 |
|
|
|a Amsterdam ;
|a Boston :
|b Elsevier/Academic Press,
|c �2011.
|
300 |
|
|
|a 1 online resource (xiii, 184 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Volume 53 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to cutting-edge microarray technology. Leading experts from academia and clinical laboratory science Volume emphasizes novel laboratory advances with application to clinical laboratory diagnostics and practical basic science studies.
|
505 |
0 |
|
|a Front Cover; Advances in Clinical Chemistry; Copyright Page; Contents; Contributors; Preface; Chapter 1: Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for multiplex genotyping; 2. Introduction; 3. Genotyping Using Mass Spectrometry; 4. MALDI-TOF-MS; 5. Multiplex Genotyping by MALDI-TOF-MS; 6. Conclusions; References; Chapter 2: Rheumatic heart disease: Mediation by complex immune events; 2. Rheumatic Heart Disease; 3. Epidemiology; 4. Genetic Susceptibility; 5. Immune Mechanisms Involved in RHD; 6. Rheumatic Heart Disease Lesions; 7. Conclusions
|
505 |
8 |
|
|a AcknowledgmentsReferences; Chapter 3: Dipeptidyl peptidase in autoimmune pathophysiology; 2. Introduction; 3. Molecular Aspects of CD26/DPPIV Role in Immunity; 4. Cellular Aspects of CD26/DPPIV Role in Immunity; 5. Clinical Aspects of CD26 Role in Immune Disorders; 6. Summary and Perspective; Acknowledgments; References; Chapter 4: Biochemistry of HELLP Syndrome; 2. Introduction; 3. Pathogenesis of HELLP and Preeclampsia: The Role of Placenta; 4. Inflammatory Response in HELLP Syndrome; 5. HELLP Syndrome, Complement Pathway, and the Coagulation System; 6. Conclusion; References
|
505 |
8 |
|
|a Chapter 5: Homocysteine in Pregnancy2. Introduction; 3. Homocysteine Metabolism; 4. Prophylactic Folic Acid, Folate Status, and Homocysteine; 5. Choline and Homocysteine; 6. Nonnutritional Factors Associated with tHcy; 7. Health Benefits of tHcy Lowering; 8. Pregnancy; Acknowledgments; References; Chapter 6: Diabetes and tuberculosis: Analysis of a Paradox; 2. Introduction; 3. Definition of the Problem; 4. Analysis of Previous Experimental Results to Solve the Paradox; 5. Probable Difference in Glycation Patterns of Macrophage Proteins and Its Precursors
|
505 |
8 |
|
|a 6. In Silico Analysis of the Possibility of Glycation-Induced Inhibition of NADPH Oxidase7. Solving the Paradox; Acknowledgment; References; Chapter 7: EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment; 3. The Role of Tea Polyphenols in Carcinogenesis; 4. In Vitro and In Vivo Preclinical Studies on Tea Polyphenols; 5. Tea Polyphenols and Their Molecular Targets in Cancer Cells; 6. Tea Polyphenol Derivatives in Cancer Studies; 7. Conclusions; Acknowledgments; References; Index
|
650 |
|
0 |
|a Clinical chemistry.
|
650 |
|
2 |
|a Chemistry, Clinical
|0 (DNLM)D002624
|
650 |
|
6 |
|a Chimie clinique.
|0 (CaQQLa)201-0016714
|
650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Clinical.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Clinical chemistry
|2 fast
|0 (OCoLC)fst00864330
|
700 |
1 |
|
|a Makowski, Gregory S.
|q (Gregory Stephen)
|
776 |
0 |
8 |
|i Print version:
|t Advances in clinical chemistry. Vol. 53.
|d Amsterdam ; Boston : Elsevier/Academic Press, �2011
|z 9780123858559
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123858559
|z Texto completo
|